Centinel Spine’s prodisc C Vivo and C Nova systems obtain MDR certification
Centinel Spine has received certification under the European Union (EU) Medical Device Regulation (MDR) for its prodisc C Vivo and…
All articles by RanjithKumar Dharma
RanjithKumar Dharma
-
-
Teleflex enrols first patient in DUBSTENT DIABETES trial
Teleflex has enrolled the first subject in the investigator-initiated DUBSTENT DIABETES trial aimed at diabetic patients undergoing percutaneous coronary intervention…
-
Beckman Coulter introduces automated BD-Tau assay for clinical research
Beckman Coulter Diagnostics has introduced a fully automated Brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test, aimed at advancing…
-
Elutia to divest bioenvelopes business to Boston Scientific for $88m
Elutia has reached a definitive agreement to sell its EluPro and CanGaroo bioenvelopes to Boston Scientific for $88m in cash.…
-
VedaBio and Mammoth Biosciences partner to enhance CRISPR diagnostic solutions
VedaBio has entered a non-exclusive licensing agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for diagnostic purposes.…
-
J&J obtains FDA approval for gemcitabine intravesical system
Johnson & Johnson (J&J) has received approval from the US Food and Drug Administration (FDA) for Inlexzo (gemcitabine intravesical system),…
-
Essentia Health launches new Alzheimer’s detection test
Essentia Health has introduced a new diagnostic test for the early detection of Alzheimer’s disease at its downtown Duluth campus…
-
Pulse Biosciences wins FDA approval for AF study using nsPFA technology
Pulse Biosciences has received approval from the US Food and Drug Administration (FDA) for its investigational device exemption (IDE) to…
-
Roche receives CE IVDR approval for Ventana label expansions
Roche has secured CE IVDR approval for its Ventana HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx assay’s label expansions, marking…
-
Aptar and Dianosic to develop ARIS technology for chronic nasal conditions
Aptar Pharma and Dianosic have entered an exclusive partnership to develop an active resorbable intranasal scaffold (ARIS) platform to treat…